XShares Advisors LLC
has launched a new ETF. The HealthShares European Medical Products and Devices ETF
, which began trading today on the New York Stock Exchange, brings the number of HealthShares ETFs to 18.
XShares Advisors LLC, a financial services company focused on the development and distribution of innovative Exchange Traded Funds (ETFs), announced that HealthShares(TM) European Medical Products and Devices ETF (HHT) began trading today on the New York Stock Exchange (NYSE). This will bring the total number of publicly traded HealthShares(TM) ETFs to 18. The previous 17 HealthShares ETFs launched earlier this year on the NYSE.
HealthShares(TM) ETFs are organized into therapeutic 'Verticals' and represent specific areas of the healthcare, life science and biotechnology industries and geographic areas. Each Vertical tracks a collection of large, mid and small-cap stocks that addresses a distinct sub-segment of healthcare, such as the diagnosis and treatment of specific therapeutic areas (e.g. cardiology, cancer, infectious disease, etc.) and the development of medical devices (e.g. orthopedic repair, cardio devices, etc.).
Each HealthShares(TM) ETF is comprised of 22-25 stocks, except the HealthShares Composite which has 80 stocks, and tracks an index that is based on a proprietary intellectual model, with well defined quantitative parameters, developed by XShares Group LLC, the parent of XShares Advisors LLC. Each Index composition calculation is administered independently by Standard & Poor's (S&P).
The company has a substantial list of additional funds in varying stages of creation, some of which use proprietary indexes and others developed in concert with strategic partners. Additional funds will be brought to market in the near future.
XShares Advisors LLC, a financial services company based in New York, is the creator of the HealthShares(TM) family of Exchange Traded Funds (ETFs). HealthShares(TM) ETFs are organized into therapeutic 'Verticals' and represent specific areas of the healthcare, life science and biotechnology industries. Each Vertical addresses a distinct sub-segment of healthcare, such as the diagnosis and treatment of specific therapeutic areas (e.g. cardiology, cancer, infectious disease, etc.) and the development of medical devices (e.g. orthopedic repair, cardio devices, etc.). Each ETF tracks an index of 22-25 stocks and offers institutional and individual investors a more precise financial instrument that leverages the potential of healthcare investing while mitigating the risks of single stock picking. For more information, visit the company's website at: http://www.healthsharesinc.com/.
XShares Advisors LLC, a subsidiary of XShares Group LLC, is a registered investment advisor that provides investment advisory services to Exchange Traded Funds. XShares also partners with major institutions and index providers seeking to bring innovative Exchange Traded Funds to market using its administrative platform. In addition, XShares creates and licenses distinctive intellectual property for its ETFs, developing products that allow for innovative trading strategies and alternative investments for the financial community. For more information, visit the company's website at http://www.xsharesadvisors.com/.
-- An Investor should consider the fund's investment objective, risks,
charges and expenses carefully before investing. For this and more
complete information about the fund call 800.925.2870 or visit the
website http://www.healthsharesinc.com/ for a prospectus. Please read
the prospectus carefully before investing.
-- There are risks involved with investing in ETFs including possible loss
of money. HealthShares(TM) are not actively managed and are subject to
risks similar to stocks, including those related to short selling and
margin maintenance. Losses from short sales may be unlimited, and
losses from purchases on margin may exceed original investment.
HealthShares(TM) ETFs are subject to increased risks associated with
investing in a specific sector compared to a more diversified
investment, as well as unique risks associated with the healthcare and
biotechnology sector (i.e., government regulation, patent regulation,
-- The ETF's face additional risks attributable to their investments in
small and medium capitalization companies which are subject to higher
volatility than larger, more established companies. In addition, they
are invested in a limited number of securities and a decline in the
value of these investments would cause the fund's overall value to
decline to a greater degree than in a less concentrated portfolio.
-- Global or International Funds invest in foreign securities that may be
subject to certain risks not associated with domestic securities, such
as currency fluctuations, and changes in political and economic
conditions. The prospectus is not an offer to buy or sell the portfolio
shares, nor is the fund soliciting an offer to buy its shares in any
jurisdiction where the offer or sale is not permitted.
HealthShares(TM) Exchange Traded Funds are distributed by ALPS Distributors, Inc.
First Call Analyst:
FCMN Contact: email@example.com
Stay ahead of the news ... Sign up for our email alerts now